Advertisement

Ads Placeholder
Loading...

PAREXEL Intl Corp.

PRXLNASDAQ
Healthcare
Medical - Diagnostics & Research
$88.08
$0.00(0.00%)
U.S. Market opens in 52h 32m

PAREXEL Intl Corp. Fundamental Analysis

PAREXEL Intl Corp. (PRXL) shows weak financial fundamentals with a PE ratio of 42.28, profit margin of 4.39%, and ROE of 16.93%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.42

Areas of Concern

Operating Margin7.83%
We analyze PRXL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 54.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
54.7/100

We analyze PRXL's fundamental strength across five key dimensions:

Efficiency Score

Weak

PRXL struggles to generate sufficient returns from assets.

ROA > 10%
4.64%

Valuation Score

Moderate

PRXL shows balanced valuation metrics.

PE < 25
42.28
PEG Ratio < 2
0.42

Growth Score

Weak

PRXL faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

PRXL shows balanced financial health with some risks.

Debt/Equity < 1
1.06
Current Ratio > 1
1.45

Profitability Score

Weak

PRXL struggles to sustain strong margins.

ROE > 15%
16.93%
Net Margin ≥ 15%
4.39%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is PRXL Expensive or Cheap?

P/E Ratio

PRXL trades at 42.28 times earnings. This suggests a premium valuation.

42.28

PEG Ratio

When adjusting for growth, PRXL's PEG of 0.42 indicates potential undervaluation.

0.42

Price to Book

The market values PAREXEL Intl Corp. at 7.15 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

7.15

EV/EBITDA

Enterprise value stands at -1.34 times EBITDA. This is generally considered low.

-1.34

How Well Does PRXL Make Money?

Net Profit Margin

For every $100 in sales, PAREXEL Intl Corp. keeps $4.39 as profit after all expenses.

4.39%

Operating Margin

Core operations generate 7.83 in profit for every $100 in revenue, before interest and taxes.

7.83%

ROE

Management delivers $16.93 in profit for every $100 of shareholder equity.

16.93%

ROA

PAREXEL Intl Corp. generates $4.64 in profit for every $100 in assets, demonstrating efficient asset deployment.

4.64%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $4.54 in free cash annually.

$4.54

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

42.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.42

vs 25 benchmark

P/B Ratio

Price to book value ratio

7.15

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.45

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.17

vs 25 benchmark

ROA

Return on assets percentage

0.05

vs 25 benchmark

ROCE

Return on capital employed

0.13

vs 25 benchmark

How PRXL Stacks Against Its Sector Peers

MetricPRXL ValueSector AveragePerformance
P/E Ratio42.2828.45 Worse (Expensive)
ROE16.93%763.00% Weak
Net Margin4.39%-45265.00% (disorted) Weak
Debt/Equity1.060.34 Weak (High Leverage)
Current Ratio1.452795.60 Neutral
ROA4.64%-16588.00% (disorted) Weak

PRXL outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews PAREXEL Intl Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ